home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Fighting Cartilage Loss in Osteoarthritis

  August, 27 2009 19:22
your information resource in human molecular genetics

The identification of a new potential therapeutic target against osteoarthritis is reported in Nature Medicine.

Osteoarthritis is a degenerative disease of the joints that leads to the progressive destruction of cartilage. A molecule known as ADAMTS-5 is known to be crucial for cartilage breakdown in patients with this disease.

Frank Echtermeyer and his colleagues now report that syndecan-4, a membrane protein, is specifically found on cartilage cells both in humans and mice with osteoarthritis. Moreover, the loss of syndecan-4 protected mice from osteoarthritic damage. The scientists found that syndecan-4 inhibition significantly decrease the activity of ADAMTS-5, thereby disclosing a previously unknown mechanism for the action of the ADAMTS-5 molecule.

These data indicate that strategies aimed at the inhibition of syndecan-4 could be of great value for the treatment of cartilage damage in osteoarthritis.

Authors contacts:

Frank Echtermeyer (Medical University Hannover, Germany)
E-mail: echtermeyer.frank@mh-hannover.de

Thomas Pap (University Hospital Munster, Germany)
E-mail: thomas.pap@uni-muenster.de

Abstract available online.

(C) Nature Medicine.

Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.